An overview of hepatocellular carcinoma with atypical enhancement pattern: spectrum of magnetic resonance imaging findings with pathologic correlation
- PMID: 33544992
- PMCID: PMC8042819
- DOI: 10.2478/raon-2021-0004
An overview of hepatocellular carcinoma with atypical enhancement pattern: spectrum of magnetic resonance imaging findings with pathologic correlation
Abstract
Background: In the setting of cirrhotic liver, the diagnosis of hepatocellular carcinoma (HCC) is straightforward when typical imaging findings consisting of arterial hypervascularity followed by portal-venous washout are present in nodules larger than 1 cm. However, due to the complexity of hepatocarcinogenesis, not all HCCs present with typical vascular behaviour. Atypical forms such as hypervascular HCC without washout, isovascular or even hypovascular HCC can pose diagnostic dilemmas. In such cases, it is important to consider also the appearance of the nodules on diffusion-weighted imaging and hepatobiliary phase. In this regard, diffusion restriction and hypointensity on hepatobiliary phase are suggestive of malignancy. If both findings are present in hypervascular lesion without washout, or even in iso- or hypovascular lesion in cirrhotic liver, HCC should be considered. Moreover, other ancillary imaging findings such as the presence of the capsule, fat content, signal intensity on T2-weighted image favour the diagnosis of HCC. Another form of atypical HCCs are lesions which show hyperintensity on hepatobiliary phase. Therefore, the aim of the present study was to provide an overview of HCCs with atypical enhancement pattern, and focus on their magnetic resonance imaging (MRI) features.
Conclusions: In order to correctly characterize atypical HCC lesions in cirrhotic liver it is important to consider not only vascular behaviour of the nodule, but also ancillary MRI features, such as diffusion restriction, hepatobiliary phase hypointensity, and T2-weighted hyperintensity. Fat content, corona enhancement, mosaic architecture are other MRI feautures which favour the diagnosis of HCC even in the absence of typical vascular profile.
Keywords: diffusion magnetic resonance imaging; hepatocellular carcinoma; liver cirrhosis; magnetic resonance imaging.
© 2021 Jelena Djokic Kovac, Aleksandar Ivanovic, Tamara Milovanovic, Marjan Micev, Francesco Alessandrino, Richard M. Gore, published by Sciendo.
Figures





Similar articles
-
Characterization of small (≤3 cm) hepatic lesions with atypical enhancement feature and hypointensity in hepatobiliary phase of gadoxetic acid-enhanced MRI in cirrhosis: A STARD-compliant article.Medicine (Baltimore). 2017 Jul;96(29):e7278. doi: 10.1097/MD.0000000000007278. Medicine (Baltimore). 2017. PMID: 28723741 Free PMC article.
-
Performance of gadoxetic acid MRI and diffusion-weighted imaging for the diagnosis of early recurrence of hepatocellular carcinoma.Eur Radiol. 2020 Jan;30(1):186-194. doi: 10.1007/s00330-019-06351-0. Epub 2019 Aug 1. Eur Radiol. 2020. PMID: 31372783
-
Value of gadoxetic acid-enhanced MRI and diffusion-weighted imaging in the differentiation of hypervascular hyperplastic nodule from small (<3 cm) hypervascular hepatocellular carcinoma in patients with alcoholic liver cirrhosis: A retrospective case-control study.J Magn Reson Imaging. 2020 Jan;51(1):70-80. doi: 10.1002/jmri.26768. Epub 2019 May 6. J Magn Reson Imaging. 2020. PMID: 31062483
-
Pearls and pitfalls in magnetic resonance imaging of hepatocellular carcinoma.World J Gastroenterol. 2020 May 7;26(17):2012-2029. doi: 10.3748/wjg.v26.i17.2012. World J Gastroenterol. 2020. PMID: 32536771 Free PMC article. Review.
-
Focal lesions in the cirrhotic liver: their pivotal role in gadoxetic acid-enhanced MRI and recognition by the Western guidelines.Dig Dis. 2014;32(6):696-704. doi: 10.1159/000368002. Epub 2014 Oct 29. Dig Dis. 2014. PMID: 25376286 Review.
Cited by
-
Machine Learning-Based CEMRI Radiomics Integrating LI-RADS Features Achieves Optimal Evaluation of Hepatocellular Carcinoma Differentiation.J Hepatocell Carcinoma. 2023 Nov 29;10:2103-2115. doi: 10.2147/JHC.S434895. eCollection 2023. J Hepatocell Carcinoma. 2023. PMID: 38050577 Free PMC article.
-
Imaging Diagnosis of Hepatocellular Carcinoma: A State-of-the-Art Review.Diagnostics (Basel). 2023 Feb 8;13(4):625. doi: 10.3390/diagnostics13040625. Diagnostics (Basel). 2023. PMID: 36832113 Free PMC article. Review.
-
Evaluating the severity of microvascular invasion in hepatocellular carcinoma, by probing the combination of enhancement modes and growth patterns through magnetic resonance imaging.Radiol Oncol. 2025 Apr 11;59(2):183-192. doi: 10.2478/raon-2025-0021. eCollection 2025 Jun 1. Radiol Oncol. 2025. PMID: 40214224 Free PMC article.
-
Preoperative differentiation of hepatocellular carcinoma with peripheral rim-like enhancement from intrahepatic mass-forming cholangiocarcinoma on contrast-enhanced MRI.Front Oncol. 2022 Nov 23;12:986713. doi: 10.3389/fonc.2022.986713. eCollection 2022. Front Oncol. 2022. PMID: 36505850 Free PMC article.
-
Classification of intrahepatic cholangiocarcinoma.Abdom Radiol (NY). 2025 Jun;50(6):2522-2532. doi: 10.1007/s00261-024-04732-8. Epub 2024 Dec 4. Abdom Radiol (NY). 2025. PMID: 39643732 Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical